Gynecological antibacterial lotion as well as preparation method and application thereof

The antibacterial lotion made of existing plant ingredients is solved by using formulas of polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, Bingpi, Huadandelion and rose extract in gynecological antibacterial lotion. The problem of insufficient effect has achieved efficient sterilization effect and product stability, and is suitable for a variety of gynecological uses.

CN119055752APending Publication Date: 2024-12-03GUANGZHOU GREENWALL BIOMEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310642957.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-01
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The antibacterial gynecological antibacterial lotion made of existing plant ingredients is insufficient in antibacterial effect, slow use efficiency, easy recurrence, and the product has a short shelf life due to the instability of the extract.

Method used

Using formulas including polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, Bingpi, Huadandelion and rose extracts to reduce the polyhexamethylene biguanide content, improve antibacterial effect, and through specific preparation Method to improve product stability.

Benefits of technology

It significantly improves the sterilization effect of gynecological antibacterial lotion, the product's sterilization effect reaches more than 99.99%, the stability is improved, and the storage period can reach 2 years. It is suitable for the treatment of gynecological diseases, wound ulcers and daily care.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004262191980000041
    Figure BDA0004262191980000041
  • Figure BDA0004262191980000051
    Figure BDA0004262191980000051
  • Figure BDA0004262191980000052
    Figure BDA0004262191980000052
Patent Text Reader

Abstract

The invention discloses a gynecological antibacterial lotion as well as a preparation method and application thereof, and relates to the technical field of gynecological external preparations. The gynecological antibacterial lotion is prepared from the following components: polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, an ilicis routundae cortex extract, a herba taraxaci extract and a rose flower extract. The gynecological antibacterial lotion is safe and free of irritation, the antibacterial effect is greatly improved, the content of polyhexamethylene biguanide is reduced, the stability of a formula is improved, and the gynecological antibacterial lotion can be used for gynecological disease treatment, sterilization and inflammation diminishing, wound ulceration treatment, daily vulva cleaning and nursing and prevention of sexual diseases, HPV virus infection and cross infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of gynecological external preparations, and in particular to a gynecological antibacterial washing liquid and a preparation method and application thereof. Background Art

[0002] Vaginitis is a common gynecological disease, which is mainly divided into bacterial vaginitis, candidal vaginitis, nonspecific vaginitis and trichomonas vaginitis. The main clinical manifestations are increased vaginal discharge, odor and vulvar itching, etc., and may also be accompanied by sexual intercourse pain, vulvar burning pain, urinary urgency, frequent urination, urinary pain and other symptoms. In severe cases, vaginal bleeding may even occur and cause other gynecological diseases.

[0003] Female antibacterial wash refers to a wash used by women to clean, eliminate bad odors, treat vaginitis, and kill pathogenic microorganisms therein to achieve the purpose of sterilization and disinfection. It is particularly different from other female washes. Female antibacterial washes have antibacterial and bactericidal effects, and the main target is patients with gynecological inflammation. At present, there are many studies on antibacterial washes. For example, Chinese patent application CN202210565308.5 discloses a stable gynecological antibacterial composition and gynecological care solution, which at least contains: ε-polylysine; vitamin B; and zein / chitosan derivatives. Experiments have shown that the antibacterial composition has excellent fungal and bacterial inhibition activity under acidic, neutral and alkaline conditions, and the antibacterial composition can significantly reduce the expression level of inflammatory factors in vaginal epithelial cells; the invention also provides a bactericidal and antipruritic gynecological care solution, which can be used to treat mixed vaginitis of VVC combined with BV; even for recurrent mixed vaginitis of RVVC combined with RBV, it also has good clinical efficacy.

[0004] Compared with Western medicine ingredients with greater irritation, lotions with Chinese medicine ingredients have received great attention due to their mild ingredients and low irritation. For example, Chinese patent application CN201911322793.8 discloses a gynecological lotion and a preparation method thereof, wherein the raw materials include the following components in parts by weight: 90-110 parts of Sophora flavescens, 90-110 parts of Cnidium monnieri, 90-110 parts of Stephania tetrandra, 90-110 parts of Phellodendron chinense, 6-9 parts of Borneolum, 9-14 parts of glycerol, 1-5 parts of rose essential oil, 4-6 parts of vitamin E, 0.1-0.3 parts of polyhexamethylene biguanide, and 1-3 parts of ethylparaben. The gynecological lotion in this invention has the advantage of improving the antibacterial effect of the product.

[0005] At present, although there are many plant ingredients that have been proven to have antibacterial properties, gynecological washes made from plant ingredients still have problems such as insufficient antibacterial effect, slow product effect, and easy recurrence in actual use. In addition, due to the instability of plant extracts, there are also shortcomings such as product instability and short shelf life. Summary of the invention

[0006] In view of this, the purpose of the present invention is to provide a gynecological antibacterial wash and its preparation method and application, which adds a variety of plant ingredients, is safe and non-irritating, greatly improves the antibacterial effect, reduces the content of polyhexamethylene biguanide, and at the same time makes the product's 1-minute bactericidal effect greater than 99.99%, and improves the stability of the formula, with a storage period of up to 2 years. The product can be used for the treatment of gynecological diseases, sterilization and anti-inflammatory, wound ulcer treatment, daily vulva cleaning and care, and prevention of sexually transmitted diseases and HPV virus infection and cross infection.

[0007] To achieve the above-mentioned object of the invention, the technical solution of the present invention is as follows:

[0008] First, the present invention provides a gynecological antibacterial wash, comprising the following ingredients: polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, ILEX ROTUNDA extract, TARAXACUM SINIC0M extract and ROSE RUGOSA flower extract.

[0009] Preferably, the gynecological antibacterial wash comprises the following ingredients by weight percentage: 0.05%-0.1% polyhexamethylene biguanide, 0.1-0.5% recombinant human lysozyme, 0.05-0.3% gallic acid, 1-5% salvia officinalis bark extract, 1-5% dandelion extract and 0.5-3% rose extract.

[0010] Further preferably, the gynecological antibacterial wash comprises the following ingredients in weight percentage: 0.06% polyhexamethylene biguanide, 0.3% recombinant human lysozyme, 0.1% gallic acid, 3% salvia officinalis bark extract, 2% dandelion extract and 1% rose extract.

[0011] Preferably, the gynecological antibacterial wash comprises the following ingredients: polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, scutellaria baicalensis peel extract, dandelion extract, rose extract, coconut oil extract, alkyl glucoside, propyl betaine, plant amino acids, polyphenols, tocopherol and water.

[0012] Further preferably, the gynecological antibacterial wash is composed of the following ingredients: polyhexamethylene biguanide 0.05%-0.1%, recombinant human lysozyme 0.1-0.5%, gallic acid 0.05-0.3%, scutellaria baicalensis peel extract 1-5%, dandelion extract 1-5%, rose extract 0.5-3%, coconut oil extract 1-5%, alkyl glucoside 2-7%, propyl betaine 1-5%, plant amino acid 1-5%, polyphenols 0.1-1%, tocopherol 0.01-0.5% and balance water.

[0013] Most preferably, the gynecological antibacterial wash consists of the following ingredients: 0.06% polyhexamethylene biguanide, 0.3% recombinant human lysozyme, 0.1% gallic acid, 3% scutellaria bark extract, 2% dandelion extract, 1% rose extract, 3% coconut oil extract, 4% alkyl glucoside, 3% propyl betaine, 2% plant amino acids, 0.5% polyphenols, 0.2% tocopherol and the remainder water.

[0014] On the basis of the plant extract formula of the present invention, other extracts with antibacterial efficacy in the art may also be added, including but not limited to Artemisia ARGYI extract, Andrographis paniculata extract, Portulaca GRANDIFLORA extract, Lonicera CONFUSA extract, etc. The addition of the above extracts will not lead to a decrease in product performance. Therefore, adding the above extracts with antibacterial efficacy on the basis of the formula of the present application falls within the protection scope of the present invention.

[0015] On the basis of the above formula, conventional additives in the art that will not affect the effect and stability of the product of the present invention may also be added, such as sodium lauryl polyoxyethylene ether sulfate, propylene glycol, etc., which should be routinely adjustable based on the formulation of this application.

[0016] On the other hand, the present invention provides a method for preparing the above-mentioned gynecological antibacterial wash, comprising the following steps:

[0017] (1) heating phase A to 80-100° C., stirring homogenously, and completely dispersing and dissolving, wherein phase A comprises a formulated amount of water, a scutellaria bark extract, a dandelion extract, and a rose extract;

[0018] (2) cooling to 30-50° C., adding phase B and stirring evenly, and pumping back the pot bottom material 5-6 times, wherein phase B includes a formula amount of polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, coconut oil extract, alkyl glucoside, propyl betaine, plant amino acids, polyphenols and tocopherol;

[0019] (3) Inspection and discharging of materials.

[0020] Preferably, in step (1), the heating temperature is 90°C.

[0021] Preferably, in step (2), the cooling temperature is 40°C.

[0022] Finally, the present invention provides the use of the above-mentioned gynecological antibacterial wash in the preparation of medicines for treating gynecological diseases and wound ulcers.

[0023] The beneficial effects of the present invention are:

[0024] (1) The present invention adds a variety of plant ingredients, which are safe and non-irritating, greatly improve the antibacterial effect, and the bactericidal effect of the product in 1 minute is greater than 99.99%, reducing the content of polyhexamethylene biguanide;

[0025] (2) The product of the present invention has a high formulation stability and a storage period of up to 2 years;

[0026] (3) The preparation method of the product of the present invention is simple, and the product has multiple properties and can be used for the treatment of gynecological diseases, sterilization and anti-inflammatory, wound ulcer treatment, daily vulva cleaning and care, and prevention of sexually transmitted diseases and HPV virus infection and cross infection. DETAILED DESCRIPTION

[0027] In order to make the technical means, creative features, purpose and efficacy of the present invention easy to understand, the present invention is further explained in conjunction with specific embodiments below, but the following embodiments are only preferred embodiments of the present invention, not all. Based on the embodiments in the implementation mode, other embodiments obtained by those skilled in the art without creative work all belong to the protection scope of the present invention. In the following embodiments, unless otherwise specified, the operating methods used are conventional operating methods, the equipment used are conventional equipment, and the equipment materials used in each embodiment are the same.

[0028] Raw material equipment information is as follows:

[0029]

[0030] Example 1

[0031] The recipe table is as follows:

[0032]

[0033] Prepared according to the following process:

[0034] (1) Heat phase A to 90°C and stir homogenously to completely disperse and dissolve;

[0035] (2) Cooling to 40°C, adding phase B and stirring evenly, and pumping back the pot bottom material for 5-6 times; (3) Discharging the material after passing the inspection to obtain the gynecological antibacterial wash liquid.

[0036] Embodiment 2 (Chinese herbal medicine extract dosage is minimum)

[0037] The recipe table is as follows:

[0038]

[0039] The preparation process is the same as that of Example 1.

[0040] Example 3 (Chinese herbal medicine extract dosage is the highest)

[0041] The recipe table is as follows:

[0042]

[0043] The preparation process is the same as that of Example 1.

[0044] The formula of Example 4 (the highest amount of polyhexamethylene biguanide) is as follows:

[0045]

[0046] The preparation process is the same as that of Example 1.

[0047] Example 5 (adding two extracts)

[0048] The recipe table is as follows:

[0049]

[0050]

[0051] The preparation process is the same as that of Example 1.

[0052] The formula of comparative example 1 (adding only Jiubiying peel) is as follows:

[0053]

[0054] The preparation process is the same as that of Example 1.

[0055] The formula of comparative example 2 (adding only rose) is as follows:

[0056]

[0057]

[0058] The preparation process is the same as that of Example 1.

[0059] Comparative Example 3 (only Chinese dandelion)

[0060] The recipe table is as follows:

[0061]

[0062] The preparation process is the same as that of Example 1.

[0063] The formula of Comparative Example 4 (without adding plant extract and increasing the amount of polyhexamethylene biguanide) is as follows:

[0064]

[0065] The preparation process is the same as that of Example 1.

[0066] Results

[0067] 1. Antimicrobial activity detection

[0068] 1.1 Equipment

[0069] Test strains: Escherichia coli 8099 and Staphylococcus aureus ATCC6538 were provided by China Industrial Microbiological Culture Collection Administration Center, 4th to 8th generation fresh slant cultures; Candida albicans ATCC10231 was provided by China Industrial Microbiological Culture Collection Administration Center, 5th to 6th generation fresh slant cultures.

[0070] Experimental samples: gynecological antibacterial wash prepared in Examples 1-5 and Comparative Examples 1-4.

[0071] Neutralizer: 4.5% lecithin, 6.5% Tween, 1.5% soap-based TSB.

[0072] Others: Standard hard water.

[0073] 1.2 Detection Method

[0074] Test according to the method in Appendix C of the Hygienic Standard for Disposable Sanitary Products GB15979-2002;

[0075] Neutralizer identification test: The original solution of the test sample was reacted with E. coli for 0.5 min at a test temperature of 19-21°C. The test was repeated 3 times.

[0076] Bactericidal performance test: The experimental sample stock solution was used for 1min, 5min, 10min, and 20min of action time, and the test temperature was 19-21℃. The experiment was repeated 3 times. The number of E. coli control colonies recovered in the experiment was 1.67×10 4 -2.80×10 4 cfu / ml; the number of colonies recovered from the control group of Staphylococcus aureus was 1.23×10 4 -2.60×10 4 cfu / ml; the number of colonies recovered from the Candida albicans control was 1.37×10 4 -2.10×10 4 cfu / ml.

[0077] 1.3 Experimental Results

[0078] The neutralizer identification experiment proves that the TSB neutralizer of 4.5% lecithin, 6.5% Tween, and 1.5% soap base can neutralize the bactericidal components in the gynecological antibacterial wash prepared in Examples 1-6 and Comparative Examples 1-5, and the neutralizer and the neutralization product have no obvious effect on the growth of the test bacteria and the culture medium, indicating that the neutralizer is suitable for the bactericidal performance test of the above samples against Escherichia coli, Staphylococcus aureus, and Candida albicans. The bactericidal performance results are as follows:

[0079]

[0080]

[0081]

[0082]

[0083] From the above results, it can be seen that the products of Examples 1-5 of the present invention have achieved significant bactericidal effects on Escherichia coli, Staphylococcus aureus and Candida albicans at a lower polyhexamethylene biguanide content. The results of Comparative Examples 1-3 show that it is difficult to achieve such a significant antibacterial effect when only one extract is added. At the same time, the products of Examples 1-5 are also due to the high dosage of polyhexamethylene biguanide products. It can be seen that the products of the present invention have better bactericidal effects, while reducing the polyhexamethylene biguanide content, the products are milder, and the safety of use is improved.

[0084] 2. Stability test

[0085] The decrease rate of polyhexamethylene biguanide content was selected to characterize the stability:

[0086] The polyhexamethylene biguanide content was tested according to GB / T 26367-2010: Technical Specification for Disinfection, 2002 edition, 2.2.3.2.1. The testing instrument was an ultraviolet spectrophotometer (UV2550), and the reagents were an aqueous solution of eosin Y (biological stain BS), sodium acetate trihydrate (analytical grade), and distilled water. The polyhexamethylene biguanide content of Examples 1-5 and Comparative Examples 1-4 before storage (0 days) and after storage (37°C for 90 days) was measured respectively. Each content value was measured 3 times and the average value was taken. The decrease rate was determined according to the following formula:

[0087] Decrease rate = (content before storage - content after storage) / content before storage × 100%

[0088] The results are as follows:

[0089]

[0090] Based on the comprehensive bactericidal effect and stability test results, the product of Example 1 has the best comprehensive performance. The product of Example 1 was further tested for safety performance and total colony count.

[0091] 3. Irritation detection

[0092] 3.1 Sample: Product solution of Example 1

[0093] 3.2 Animals and husbandry

[0094] Animal Origin:

[0095]

[0096] Feeding environment:

[0097] Room temperature range 20.8-23.4℃ Relative humidity 55.6-68.9% Lighting control 12h light / dark cycle Ventilation 3 Feed source Tongxiang Yinhai Animal Husbandry Professional Cooperative Drinking water Free drinking water

[0098] 3.3 Test methods:

[0099] The hair on both sides of the spine of the experimental animal's back was cut off, and the hair removal range was 3×3cm each, and the coating area was 2.5×2.5cm. 0.5ml of the original solution of Example 1 was applied to one side of the skin, and the other side was used as a control. After 4 hours of application, the residue was washed off with water. The application was applied once a day for 14 consecutive days. The results were observed 24 hours after each application, and the scores and grades were performed according to GB 15979-2002. In order to facilitate application and observation, the hair was cut when necessary. The treatment method of the control area was the same as that of the test area.

[0100] The results are as follows:

[0101]

[0102]

[0103] It can be seen that the results of multiple intact skin irritation tests on rabbits of the sample solution of Example 1 were non-irritating and no other toxicity was observed.

[0104] 4. Total colony count detection

[0105] The test was conducted in accordance with Appendix B of the Sanitary Standard for Disposable Sanitary Products GB15979-2002, with a test temperature of 19-21°C. The sample was the original solution of Example 1. The results are as follows:

[0106] project result Total bacterial colony count (cfu / ml) <4 Escherichia coli Not detected Pseudomonas aeruginosa Not detected Staphylococcus aureus Not detected Hemolytic Streptococcus Not detected Total fungal colonies (cfu / ml) <4

[0107] It can be seen that the microbial indicators of the product prepared by the present invention meet the standards.

[0108] In summary, the formula product of the present invention greatly reduces the content of polyhexamethylene biguanide by adding the extract of the Chinese scutellaria bark, the extract of the Chinese dandelion and the extract of the rose, and improves the safety of use. At the same time, the addition of the above extracts makes the product more stable. According to evaluation, the storage period of the product of Example 1 can reach 2 years. At the same time, the prepared formula product is non-irritating, the total number of colonies meets the hygiene standards, and has good production and application prospects.

[0109] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A gynecological antibacterial wash, characterized in that: Includes the following ingredients: polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, scutellaria bark extract, dandelion extract and rose flower extract.

2. The gynecological antibacterial wash according to claim 1, characterized in that: The gynecological antibacterial washing liquid comprises the following components in percentage by weight: 0.05%-0.1% of polyhexamethylene biguanide, 0.1%-0.5% of recombinant human lysozyme, 0.05%-0.3% of gallic acid, 1%-5% of scutellaria baicalensis bark extract, 1%-5% of dandelion extract and 0.5%-3% of rose extract.

3. The gynecological antibacterial wash according to claim 2, characterized in that: The gynecological antibacterial washing liquid comprises the following components in percentage by weight: 0.06% of polyhexamethylene biguanide, 0.3% of recombinant human lysozyme, 0.1% of gallic acid, 3% of scutellaria baicalensis bark extract, 2% of dandelion extract and 1% of rose extract.

4. The gynecological antibacterial wash according to claim 1, characterized in that: The gynecological antibacterial wash comprises the following ingredients: polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, scutellaria baicalensis peel extract, dandelion extract, rose flower extract, coconut oil extract, alkyl glucoside, propyl betaine, plant amino acid, benzyl alcohol, tocopherol and water.

5. The gynecological antibacterial wash according to claim 4, characterized in that: The gynecological antibacterial washing liquid is composed of the following ingredients: 0.05%-0.1% of polyhexamethylene biguanide, 0.1%-0.5% of recombinant human lysozyme, 0.05%-0.3% of gallic acid, 1%-5% of scutellaria baicalensis peel extract, 1%-5% of dandelion extract, 0.5%-3% of rose flower extract, 1%-5% of coconut oil extract, 2%-7% of alkyl glucoside, 1%-5% of propyl betaine, 1-5% of plant amino acid, 0.1%-1% of polyphenols, 0.01%-0.5% of tocopherol and the balance of water.

6. The gynecological antibacterial wash according to claim 5, characterized in that: The gynecological antibacterial wash consists of the following ingredients: 0.06% polyhexamethylene biguanide, 0.3% recombinant human lysozyme, 0.1% gallic acid, 3% scutellaria baicalensis peel extract, 2% dandelion extract, 1% rose flower extract, 3% coconut oil extract, 4% alkyl glucoside, 3% propyl betaine, 2% plant amino acid, 0.5% polyphenol, 0.2% tocopherol and the balance water.

7. The method for preparing the gynecological antibacterial wash according to any one of claims 1 to 6, characterized in that: The following steps are involved: (1) heating phase A to 80-100° C., stirring homogenously, and completely dispersing and dissolving, wherein phase A comprises a formulated amount of water, a scutellaria bark extract, a dandelion extract, and a rose extract; (2) cooling to 30-50° C., adding phase B and stirring evenly, and pumping back the pot bottom material 5-6 times, wherein phase B includes a formula amount of polyhexamethylene biguanide, recombinant human lysozyme, gallic acid, coconut oil extract, alkyl glucoside, propyl betaine, plant amino acids, polyphenols and tocopherol; (3) Inspection and discharging of materials.

8. The preparation method according to claim 7, characterized in that: In step (1), the heating temperature is 90°C.

9. The preparation method according to claim 7, characterized in that: In step (2), the cooling temperature is 40°C.

10. Use of the gynecological antibacterial wash according to any one of claims 1 to 6 in the preparation of medicines for treating gynecological diseases and wound ulcers.